<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Jiang B</submitter><funding>Major Basic Research Project of the Natural Science Foundation of the Jiangsu Higher Education Institutions</funding><funding>National Natural Science Foundation of China</funding><funding>Natural Science Research of Jiangsu Higher Education Institutions of China</funding><pagination>101462</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC8938331</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>59</volume><pubmed_abstract>&lt;h4>Objective&lt;/h4>Chronic inflammatory response plays a prominent role in obesity-related nonalcoholic fatty liver disease (NAFLD). However, the intrahepatic triggering mechanism of inflammation remains obscure. This study aimed to elucidate the role of serum amyloid A1 (SAA1), an acute-phase response protein, in the obesity-induced hepatic inflammation and NAFLD.&lt;h4>Methods&lt;/h4>Male mice were fed a high fat diet (HFD) for 16 weeks, and insulin resistance, hepatic steatosis, and inflammation in mice were monitored. Murine SAA1/2 was genetically manipulated to investigate the role of SAA1 in NAFLD.&lt;h4>Results&lt;/h4>We found that SAA1 was increased in the NAFLD liver in both humans and mice. Knockout of SAA1/2 or knockdown of hepatic SAA1/2 promoted energy expenditure and alleviated HFD-induce</pubmed_abstract><journal>Molecular metabolism</journal><pubmed_title>Serum amyloid A1 exacerbates hepatic steatosis via TLR4-mediated NF-κB signaling pathway.</pubmed_title><pmcid>PMC8938331</pmcid><funding_grant_id>20KJA310007</funding_grant_id><funding_grant_id>81830011</funding_grant_id><funding_grant_id>18KJA310003</funding_grant_id><funding_grant_id>81870371</funding_grant_id><funding_grant_id>82070457</funding_grant_id><funding_grant_id>81770417</funding_grant_id><funding_grant_id>82030012</funding_grant_id><funding_grant_id>82100433</funding_grant_id><funding_grant_id>81670263</funding_grant_id><pubmed_authors>Chen Q</pubmed_authors><pubmed_authors>Hu Y</pubmed_authors><pubmed_authors>Ben J</pubmed_authors><pubmed_authors>Wang D</pubmed_authors><pubmed_authors>Zhang H</pubmed_authors><pubmed_authors>Li W</pubmed_authors><pubmed_authors>Yang X</pubmed_authors><pubmed_authors>Li X</pubmed_authors><pubmed_authors>Jiang B</pubmed_authors><pubmed_authors>Zhu X</pubmed_authors><pubmed_authors>Yang Q</pubmed_authors><pubmed_authors>Bai H</pubmed_authors><pubmed_authors>Liu F</pubmed_authors></additional><is_claimable>false</is_claimable><name>Serum amyloid A1 exacerbates hepatic steatosis via TLR4-mediated NF-κB signaling pathway.</name><description>&lt;h4>Objective&lt;/h4>Chronic inflammatory response plays a prominent role in obesity-related nonalcoholic fatty liver disease (NAFLD). However, the intrahepatic triggering mechanism of inflammation remains obscure. This study aimed to elucidate the role of serum amyloid A1 (SAA1), an acute-phase response protein, in the obesity-induced hepatic inflammation and NAFLD.&lt;h4>Methods&lt;/h4>Male mice were fed a high fat diet (HFD) for 16 weeks, and insulin resistance, hepatic steatosis, and inflammation in mice were monitored. Murine SAA1/2 was genetically manipulated to investigate the role of SAA1 in NAFLD.&lt;h4>Results&lt;/h4>We found that SAA1 was increased in the NAFLD liver in both humans and mice. Knockout of SAA1/2 or knockdown of hepatic SAA1/2 promoted energy expenditure and alleviated HFD-induce</description><dates><release>2022-01-01T00:00:00Z</release><publication>2022 May</publication><modification>2025-04-04T08:53:28.589Z</modification><creation>2025-04-04T08:53:28.589Z</creation></dates><accession>S-EPMC8938331</accession><cross_references><pubmed>35247611</pubmed><doi>10.1016/j.molmet.2022.101462</doi></cross_references></HashMap>